The9 Stock Forecast, Price & News

Wall Street analysts have given The9 a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but The9 wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

The9 saw a decrease in short interest during the month of March. As of March 15th, there was short interest totaling 557,600 shares, a decrease of 18.0% from the February 28th total of 679,700 shares. Based on an average trading volume of 4,800,000 shares, the short-interest ratio is currently 0.1 days. Currently, 9.5% of the company's shares are short sold.
View The9's Short Interest.

The9's stock was trading at $6.3870 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, NCTY shares have increased by 295.0% and is now trading at $25.23.
View which stocks have been most impacted by COVID-19.

The9's stock reverse split before market open on Monday, October 19th 2020. The 1-10 reverse split was announced on Tuesday, October 13th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Friday, October 16th 2020. An investor that had 100 shares of The9 stock prior to the reverse split would have 10 shares after the split.

Some companies that are related to The9 include comScore (SCOR), ICTS International (ICTSF), Points International (PCOM), PaySign (PAYS), RTCORE (PPPS), MOGU (MOGU), DHI Group (DHX), PFSweb (PFSW), ServiceSource International (SREV), Exela Technologies (XELA), 36Kr (KRKR), Logiq (LGIQ), Molecular Data (MKD), Steel Connect (STCN) and China Customer Relations Centers (CCRC).
View all of NCTY's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other The9 investors own include Amarin (AMRN), Gevo (GEVO), Biocept (BIOC), Nabriva Therapeutics (NBRV), Occidental Petroleum (OXY), Acasti Pharma (ACST), Anavex Life Sciences (AVXL), BIOLASE (BIOL), EyePoint Pharmaceuticals (EYPT) and Jaguar Health (JAGX).

The9 trades on the NASDAQ under the ticker symbol "NCTY."

Shares of NCTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NCTY stock can currently be purchased for approximately $25.23.

The9 has a market capitalization of $76.70 million and generates $50,000.00 in revenue each year.

The9 employs 61 workers across the globe.

The official website for The9 is www.the9.com.

The9 is headquartered at BUILDING NO.3 690 BIBO ROAD ZHANG JIANG HI-TECH PARK, SHANGHAI F4, 201203.

The9's mailing address is BUILDING NO.3 690 BIBO ROAD ZHANG JIANG HI-TECH PARK, SHANGHAI F4, 201203. The technology company can be reached via phone at 86-21-5172-9999 or via email at [email protected]